Specify a stock or a cryptocurrency in the search bar to get a summary
Titan Pharmaceuticals Inc
TTNPTitan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of chronic diseases in the United States and internationally. It develops products based on ProNeura, a proprietary long-term drug delivery platform. It also develops TP-2021 in combination with ProNeura technology for the treatment of chronic pruritus, a severe and debilitating condition defined as itching of the skin lasting longer than six weeks; and Nalmefene implant program for the prevention of opioid relapse following detoxification of patients suffering opioid use disorder. The company was founded in 1991 and is based in South San Francisco, California. Address: 400 Oyster Point Boulevard, South San Francisco, CA, United States, 94080
Analytics
WallStreet Target Price
7 USDP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures TTNP
Dividend Analytics TTNP
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History TTNP
Stock Valuation TTNP
Financials TTNP
Results | 2019 | Dynamics |